PMID: 25735366Mar 5, 2015Paper

Geographic disparities in prostate cancer outcomes--review of international patterns

Asian Pacific Journal of Cancer Prevention : APJCP
Peter D BaadeSuzanne K Chambers

Abstract

This study reviewed the published evidence as to how prostate cancer outcomes vary across geographical remoteness and area level disadvantage. A review of the literature published from January 1998 to January 2014 was undertaken: Medline and CINAHL databases were searched in February to May 2014. The search terms included terms of 'Prostate cancer' and 'prostatic neoplasms' coupled with 'rural health', 'urban health', 'geographic inequalities', 'spatial', 'socioeconomic', 'disadvantage', 'health literacy' or 'health service accessibility'. Outcome specific terms were 'incidence', 'mortality', 'prevalence', 'survival', 'disease progression', 'PSA testing' or 'PSA screening', 'treatment', 'treatment complications' and 'recurrence'. A further search through internet search engines was conducted to identify any additional relevant published reports. 91 papers were included in the review. While patterns were sometimes contrasting, the predominate patterns were for PSA testing to be more common in urban (5 studies out of 6) and affluent areas (2 of 2), higher prostate cancer incidence in urban (12 of 22) and affluent (18 of 20), greater risk of advanced stage prostate cancer in rural (7 of 11) and disadvantaged (8 of 9), higher survi...Continue Reading

References

Jan 1, 1997·Annual Review of Public Health·N KriegerN E Moss
Jun 9, 1998·Japanese Journal of Cancer Research : Gann·C Y Yang, Y L Hsieh
Feb 22, 2000·Annals of the New York Academy of Sciences·N E Adler, J M Ostrove
Jun 6, 2000·British Journal of Cancer·N C CampbellJ Little
May 3, 2001·Journal of the National Cancer Institute·L LiuD Deapen
Jan 25, 2002·International Journal of Cancer. Journal International Du Cancer·Lars JarupPaul Elliott
Apr 9, 2002·Cancer Causes & Control : CCC·Angela MariottoLimin X Clegg
Sep 5, 2002·International Journal of Cancer. Journal International Du Cancer·Ahmedin JemalJoseph F Fraumeni
Nov 26, 2002·International Journal of Cancer. Journal International Du Cancer·Eero Pukkala, Elisabete Weiderpass
Dec 17, 2003·Cancer Causes & Control : CCC·Kendra L SchwartzMousumi Banerjee
Apr 1, 2004·British Journal of Cancer·M P ColemanJ Estève
Jun 18, 2004·The Medical Journal of Australia·Katharine E JongBruce K Armstrong
Jul 6, 2004·Australian and New Zealand Journal of Public Health·Gavin TurrellDamien Jolley
Mar 16, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Ahmedin JemalMichael J Thun
Jun 16, 2005·Health & Place·Robert PampalonDenis Hamel
Jan 18, 2006·American Journal of Preventive Medicine·Jingzhen YangJohn Lundell
Jan 18, 2006·American Journal of Preventive Medicine·Russell E GlasgowDiane K King
Jan 18, 2006·American Journal of Preventive Medicine·Joel L Nitzkin
Feb 7, 2006·American Journal of Preventive Medicine·Peter A RogersonDaikwon Han
Jul 18, 2006·Annals of Epidemiology·Maureen SandersonMary K Fadden
Dec 21, 2006·Health Promotion Journal of Australia : Official Journal of Australian Association of Health Promotion Professionals·Lareen NewmanElizabeth Harris
Dec 21, 2006·International Journal of Health Geographics·Laurie M DeChelloHolly Samociuk
Apr 24, 2007·Annals of Epidemiology·David I GregorioMartin Kulldorff
Sep 25, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A P JonesD Forman
Feb 13, 2008·BMC Public Health·Giedre Smailyte, Juozas Kurtinaitis
Apr 1, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A P JonesD Forman
Jun 25, 2008·Social Science & Medicine·Robin HaynesRoss Barnett
Aug 1, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Kristoffer MarsåSøren Friis
Oct 1, 2008·British Journal of Cancer·S RowanM P Coleman
Oct 31, 2008·Australian and New Zealand Journal of Public Health·Andrew HayenDianne L O'Connell
Dec 23, 2008·Molecular Nutrition & Food Research·Peter D BaadeLauren J Krnjacki
Feb 23, 2010·Journal of Health Care for the Poor and Underserved·Xiaoling NiuLisa M Roche
Apr 22, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anobel Y OdishoPeter R Carroll

❮ Previous
Next ❯

Citations

Sep 30, 2016·Cancer Epidemiology·Mónica S SierraDavid Forman
Sep 30, 2016·Cancer Epidemiology·Mónica S SierraDavid Forman
Aug 3, 2016·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Francisco PinaNuno Lunet
Oct 2, 2019·International Journal of Health Geographics·Earl W DuncanPeter D Baade
Jul 22, 2018·BMC Public Health·Catherine R BrownUNKNOWN U.S. Caribbean Alliance for Health Disparities Research Group (USCAHDR)
May 26, 2016·Asian Pacific Journal of Cancer Prevention : APJCP·Jophy VargheseH Krishnamorthy
Mar 5, 2021·International Journal of Urology : Official Journal of the Japanese Urological Association·Shingo Hatakeyama, Chikara Ohyama
Feb 26, 2021·International Journal of Urology : Official Journal of the Japanese Urological Association·Masaki ShiotaUNKNOWN Japan Study Group of Prostate Cancer (J-CaP)

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.